NASDAQ:ILMN - Nasdaq - US4523271090 - Common Stock - Currency: USD
Taking everything into account, ILMN scores 5 out of 10 in our fundamental rating. ILMN was compared to 55 industry peers in the Life Sciences Tools & Services industry. ILMN has an average financial health and profitability rating. ILMN is not valued too expensively and it also shows a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -15.61% | ||
ROE | -40.75% | ||
ROIC | 15.23% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 21.07% | ||
PM (TTM) | N/A | ||
GM | 66.34% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.63 | ||
Debt/FCF | 2.27 | ||
Altman-Z | 3.28 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.86 | ||
Quick Ratio | 1.48 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.35 | ||
Fwd PE | 17.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 15.26 | ||
EV/EBITDA | 11.39 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
84.43
+1.94 (+2.35%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 25.35 | ||
Fwd PE | 17.62 | ||
P/S | 3.08 | ||
P/FCF | 15.26 | ||
P/OCF | 13.37 | ||
P/B | 5.64 | ||
P/tB | 13.68 | ||
EV/EBITDA | 11.39 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -15.61% | ||
ROE | -40.75% | ||
ROCE | 19.27% | ||
ROIC | 15.23% | ||
ROICexc | 20.6% | ||
ROICexgc | 34.16% | ||
OM | 21.07% | ||
PM (TTM) | N/A | ||
GM | 66.34% | ||
FCFM | 20.2% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.63 | ||
Debt/FCF | 2.27 | ||
Debt/EBITDA | 1.21 | ||
Cap/Depr | 39.37% | ||
Cap/Sales | 2.86% | ||
Interest Coverage | 250 | ||
Cash Conversion | 81.37% | ||
Profit Quality | N/A | ||
Current Ratio | 1.86 | ||
Quick Ratio | 1.48 | ||
Altman-Z | 3.28 |